IVF HARTMANN Holding AG Logo

IVF HARTMANN Holding AG

Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.

VBSN | SW

Overview

Corporate Details

ISIN(s):
CH0187624256
LEI:
Country:
Switzerland
Address:
Victor-von-Bruns-Strasse 28, 8212 Neuhausen am Rheinfall
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

IVF HARTMANN Holding AG is a Swiss-based holding company engaged in the production and distribution of medical supplies and consumer goods. As a leading manufacturer in Switzerland for over 150 years, the company serves as a key supplier to the national healthcare industry. Its product portfolio includes a wide range of medical, pharmaceutical, and hygiene items, such as wound care dressings, bandages, surgical disposables, first-aid supplies, and accident prevention products. The company provides these essential goods to both the Swiss market and internationally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IVF HARTMANN Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVF HARTMANN Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVF HARTMANN Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-08-23 N/A Non-Executive member Buy None 11,200.00 CHF
2023-08-21 N/A Non-Executive member Buy None 11,200.00 CHF

Peer Companies

Company Country Ticker View
IOVANCE BIOTHERAPEUTICS, INC. Logo
Developing personalized T-cell immunotherapies (TIL) to fight solid tumors and blood cancers.
United States of America IOVA
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
Develops and commercializes therapies for GI diseases like IBS-C and chronic constipation.
United States of America IRWD
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea 086890
Iterum Therapeutics plc Logo
Develops novel oral & IV anti-infectives to combat multi-drug resistant pathogens.
United States of America ITRM
Jade Biosciences, Inc. Logo
Clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America JBIO
Jaguar Health, Inc. Logo
Develops plant-based, non-opioid GI therapies for humans and animals.
United States of America JAGX
Janux Therapeutics, Inc. Logo
Developing tumor-activated immunotherapies to treat cancer while minimizing systemic toxicities.
United States of America JANX
Japan Tissue Engineering Co., Ltd. Logo
Pioneers regenerative medicine with tissue products, CDMO services, and research models.
Japan 7774

Talk to a Data Expert

Have a question? We'll get back to you promptly.